Glenmark Pharmaceuticals Limited (NSE:GLENMARK)
India · Delayed Price · Currency is INR 2,235.00
+4.30 (0.19%)
Apr 21, 2026, 3:29 PM IST
Glenmark Pharmaceuticals Revenue
Glenmark Pharmaceuticals had revenue of 39.01B INR in the quarter ending December 31, 2025, with 15.15% growth. This brings the company's revenue in the last twelve months to 165.10B, up 18.26% year-over-year. In the fiscal year ending March 31, 2025, Glenmark Pharmaceuticals had annual revenue of 133.63B with 5.68% growth.
Revenue (ttm)
165.10B
Revenue Growth
+18.26%
P/S Ratio
3.81
Revenue / Employee
10.45M
Employees
15,800
Market Cap
629.51B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2025 | 133.63B | 7.18B | 5.68% |
| Mar 31, 2024 | 126.45B | 9.90B | 8.49% |
| Mar 31, 2023 | 116.56B | -6.49B | -5.28% |
| Mar 31, 2022 | 123.05B | 13.61B | 12.44% |
| Mar 31, 2021 | 109.44B | 2.87B | 2.69% |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Aurobindo Pharma | 331.82B |
| Cipla | 279.67B |
| Zydus Lifesciences | 260.89B |
| Alkem Laboratories | 142.53B |
| Mankind Pharma | 139.14B |
| Divi's Laboratories | 103.14B |
| Ipca Laboratories | 95.06B |
| Emcure Pharmaceuticals | 88.50B |
Glenmark Pharmaceuticals News
- 5 days ago - Pharma sector stocks today, April 16: Ajanta Pharma down 1.53%, Glenmark Pharma falls 1.23%, Lupin drops 1.08% - Business Upturn
- 11 days ago - Glenmark Secures FDA Approval For Progesterone Vaginal Inserts, 100 Mg - Nasdaq
- 12 days ago - Pharma sector stocks today, April 9: Senores Pharma up 2.48%, Jubilant Pharmova down 2.02%, Glenmark Pharma falls 1.11% - Business Upturn
- 12 days ago - Glenmark Pharmaceuticals receives U.S. FDA approval for progesterone vaginal inserts - Business Upturn
- 20 days ago - Pharma sector stocks rally sharply today, April 1: Marksans Pharma jumps 6%, Alembic gains 5.37%, Glenmark Pharma surge 4.30% - Business Upturn
- 4 weeks ago - Pharma sector stocks today, March 24: Shilpa Medicare jumps 3.28%, Glenmark Pharma up 1.36%, Laurus Labs gain 1.65% - Business Upturn
- 4 weeks ago - Pharma sector stocks today, March 23: Alembic Pharma down 2.24%, Ajanta Pharma falls 1.85%, Glenmark Pharma falls 1.98% - Business Upturn
- 4 weeks ago - Pharma sector stocks fall today, March 19: Biocon down 2.33%, Laurus Labs falls 2.29%, Glenmark Pharma drops 2% - Business Upturn